Global Isoxazolines Drugs Market

Isoxazolines Drugs Comprehensive Study by Type (Sarolaner, Lotilaner, Fluralaner, Afoxolaner), Pets (Cat, Dog) Players and Region - Global Market Outlook to 2030

Isoxazolines Drugs Market by XX Submarkets | Forecast Years 2024-2030  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
About Isoxazolines Drugs
Isoxazoline is a fairly new chemical category of five-membered heterocyclic chemical compounds that consists of one atom every of oxygen and nitrogen placed adjoining to one another. Isoxazolines are pesticides of a chemical class. They had been launched first as veterinary merchandise towards fleas and ticks in dogs, however are additionally superb in opposition to severa different exterior veterinary and agricultural parasites. They have a vast spectrum of insecticidal and acaricidal endeavor and are wonderful in opposition to a wide variety of veterinary parasites such as fleas and ticks. Isoxazolines accepted for veterinary use have a systemic mode of action.

AttributesDetails
Study Period2018-2030
Base Year2023
UnitValue (USD Million)


The market is seeing moderate market players, by seeing huge growth in this market the key leading vendors are highly focusing towards the production technologies, efficiency enhancement and product life. There is various growth opportunity in this market which is captured by leading players via tracking the ongoing process enhancement and huge invest in market growth strategies. Established and emerging Players should take a closer view at their existing organizations and reinvent traditional business and operating models to adapt to the future.

Zoetis Inc. (United States), Elanco Animal Health Incorporated (United States), Boehringer Ingelheim International GmbH (Germany) and Elanco Animal Health Incorporated (United States) are some of the key players that are part of study coverage.

Segmentation Overview
AMA Research has segmented the market of Global Isoxazolines Drugs market by Type (Sarolaner, Lotilaner, Fluralaner and Afoxolaner) and Region.



On the basis of geography, the market of Isoxazolines Drugs has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by Pets, the sub-segment i.e. Cat will boost the Isoxazolines Drugs market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Influencing Trend:
Environment-friendly Interventions to Increase the Availability of Efficacious Treatments

Market Growth Drivers:
Increase in Expenditure on Pets

Restraints:
Increase in Government Regulations on Isoxazoline-based tick Repellents

Opportunities:
Rise in Disposable income and Rapid Urbanization are key factors prompting people to Adopt Pets and Regulatory Factor

Market Leaders and their expansionary development strategies

July 2020, Boehringer Ingelheim International GmbH launched NexGard and Broadline brand of Isoxazoline-based tick/flea repellent in India. These factors are expected to provide lucrative opportunities to the U.S.-based manufacturers such as Merck Animal Health Inc., Elanco Animal Health Incorporated, and Zoetis Inc. to export their products to China and India.
In August 2021 The FDA has extended this alert to cats. Some treated animals have experienced adverse events such as muscle tremors, ataxia (lack of voluntary coordination of muscle movements), and seizures. This regards all products containing isoxazolines.

Key Target Audience
Venture Capitalists and Private Equity Firms, Government Bodies, Corporate Entities, Government and Private Research Organizations and Others

About Approach
To evaluate and validate the market size various sources including primary and secondary analysis is utilized. AMA Research follows regulatory standards such as NAICS/SIC/ICB/TRCB, to have a better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with the purpose to understand the companies positioning regarding the market value, volume, and their market share for regional as well as global.

Further to bring relevance specific to any niche market we set and apply a number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders, etc., and work towards appointment generation.

The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, the analyst team keeps preparing a set of questionnaires, and after getting the appointee list; the target audience is then tapped and segregated with various mediums and channels that are feasible for making connections that including email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey, etc.

Report Objectives / Segmentation Covered

By Type
  • Sarolaner
  • Lotilaner
  • Fluralaner
  • Afoxolaner
By Pets
  • Cat
  • Dog

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increase in Expenditure on Pets
    • 3.3. Market Trends
      • 3.3.1. Environment-friendly Interventions to Increase the Availability of Efficacious Treatments
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Isoxazolines Drugs, by Type, Pets and Region (value and price ) (2018-2023)
    • 5.1. Introduction
    • 5.2. Global Isoxazolines Drugs (Value)
      • 5.2.1. Global Isoxazolines Drugs by: Type (Value)
        • 5.2.1.1. Sarolaner
        • 5.2.1.2. Lotilaner
        • 5.2.1.3. Fluralaner
        • 5.2.1.4. Afoxolaner
      • 5.2.2. Global Isoxazolines Drugs by: Pets (Value)
        • 5.2.2.1. Cat
        • 5.2.2.2. Dog
      • 5.2.3. Global Isoxazolines Drugs Region
        • 5.2.3.1. South America
          • 5.2.3.1.1. Brazil
          • 5.2.3.1.2. Argentina
          • 5.2.3.1.3. Rest of South America
        • 5.2.3.2. Asia Pacific
          • 5.2.3.2.1. China
          • 5.2.3.2.2. Japan
          • 5.2.3.2.3. India
          • 5.2.3.2.4. South Korea
          • 5.2.3.2.5. Taiwan
          • 5.2.3.2.6. Australia
          • 5.2.3.2.7. Rest of Asia-Pacific
        • 5.2.3.3. Europe
          • 5.2.3.3.1. Germany
          • 5.2.3.3.2. France
          • 5.2.3.3.3. Italy
          • 5.2.3.3.4. United Kingdom
          • 5.2.3.3.5. Netherlands
          • 5.2.3.3.6. Rest of Europe
        • 5.2.3.4. MEA
          • 5.2.3.4.1. Middle East
          • 5.2.3.4.2. Africa
        • 5.2.3.5. North America
          • 5.2.3.5.1. United States
          • 5.2.3.5.2. Canada
          • 5.2.3.5.3. Mexico
    • 5.3. Global Isoxazolines Drugs (Price)
      • 5.3.1. Global Isoxazolines Drugs by: Type (Price)
  • 6. Isoxazolines Drugs: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
    • 6.2. Peer Group Analysis (2023)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Zoetis Inc. (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Elanco Animal Health Incorporated (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Boehringer Ingelheim International GmbH (Germany)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Elanco Animal Health Incorporated (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
  • 7. Global Isoxazolines Drugs Sale, by Type, Pets and Region (value and price ) (2025-2030)
    • 7.1. Introduction
    • 7.2. Global Isoxazolines Drugs (Value)
      • 7.2.1. Global Isoxazolines Drugs by: Type (Value)
        • 7.2.1.1. Sarolaner
        • 7.2.1.2. Lotilaner
        • 7.2.1.3. Fluralaner
        • 7.2.1.4. Afoxolaner
      • 7.2.2. Global Isoxazolines Drugs by: Pets (Value)
        • 7.2.2.1. Cat
        • 7.2.2.2. Dog
      • 7.2.3. Global Isoxazolines Drugs Region
        • 7.2.3.1. South America
          • 7.2.3.1.1. Brazil
          • 7.2.3.1.2. Argentina
          • 7.2.3.1.3. Rest of South America
        • 7.2.3.2. Asia Pacific
          • 7.2.3.2.1. China
          • 7.2.3.2.2. Japan
          • 7.2.3.2.3. India
          • 7.2.3.2.4. South Korea
          • 7.2.3.2.5. Taiwan
          • 7.2.3.2.6. Australia
          • 7.2.3.2.7. Rest of Asia-Pacific
        • 7.2.3.3. Europe
          • 7.2.3.3.1. Germany
          • 7.2.3.3.2. France
          • 7.2.3.3.3. Italy
          • 7.2.3.3.4. United Kingdom
          • 7.2.3.3.5. Netherlands
          • 7.2.3.3.6. Rest of Europe
        • 7.2.3.4. MEA
          • 7.2.3.4.1. Middle East
          • 7.2.3.4.2. Africa
        • 7.2.3.5. North America
          • 7.2.3.5.1. United States
          • 7.2.3.5.2. Canada
          • 7.2.3.5.3. Mexico
    • 7.3. Global Isoxazolines Drugs (Price)
      • 7.3.1. Global Isoxazolines Drugs by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Isoxazolines Drugs: by Type(USD Million)
  • Table 2. Isoxazolines Drugs Sarolaner , by Region USD Million (2018-2023)
  • Table 3. Isoxazolines Drugs Lotilaner , by Region USD Million (2018-2023)
  • Table 4. Isoxazolines Drugs Fluralaner , by Region USD Million (2018-2023)
  • Table 5. Isoxazolines Drugs Afoxolaner , by Region USD Million (2018-2023)
  • Table 6. Isoxazolines Drugs: by Pets(USD Million)
  • Table 7. Isoxazolines Drugs Cat , by Region USD Million (2018-2023)
  • Table 8. Isoxazolines Drugs Dog , by Region USD Million (2018-2023)
  • Table 9. South America Isoxazolines Drugs, by Country USD Million (2018-2023)
  • Table 10. South America Isoxazolines Drugs, by Type USD Million (2018-2023)
  • Table 11. South America Isoxazolines Drugs, by Pets USD Million (2018-2023)
  • Table 12. Brazil Isoxazolines Drugs, by Type USD Million (2018-2023)
  • Table 13. Brazil Isoxazolines Drugs, by Pets USD Million (2018-2023)
  • Table 14. Argentina Isoxazolines Drugs, by Type USD Million (2018-2023)
  • Table 15. Argentina Isoxazolines Drugs, by Pets USD Million (2018-2023)
  • Table 16. Rest of South America Isoxazolines Drugs, by Type USD Million (2018-2023)
  • Table 17. Rest of South America Isoxazolines Drugs, by Pets USD Million (2018-2023)
  • Table 18. Asia Pacific Isoxazolines Drugs, by Country USD Million (2018-2023)
  • Table 19. Asia Pacific Isoxazolines Drugs, by Type USD Million (2018-2023)
  • Table 20. Asia Pacific Isoxazolines Drugs, by Pets USD Million (2018-2023)
  • Table 21. China Isoxazolines Drugs, by Type USD Million (2018-2023)
  • Table 22. China Isoxazolines Drugs, by Pets USD Million (2018-2023)
  • Table 23. Japan Isoxazolines Drugs, by Type USD Million (2018-2023)
  • Table 24. Japan Isoxazolines Drugs, by Pets USD Million (2018-2023)
  • Table 25. India Isoxazolines Drugs, by Type USD Million (2018-2023)
  • Table 26. India Isoxazolines Drugs, by Pets USD Million (2018-2023)
  • Table 27. South Korea Isoxazolines Drugs, by Type USD Million (2018-2023)
  • Table 28. South Korea Isoxazolines Drugs, by Pets USD Million (2018-2023)
  • Table 29. Taiwan Isoxazolines Drugs, by Type USD Million (2018-2023)
  • Table 30. Taiwan Isoxazolines Drugs, by Pets USD Million (2018-2023)
  • Table 31. Australia Isoxazolines Drugs, by Type USD Million (2018-2023)
  • Table 32. Australia Isoxazolines Drugs, by Pets USD Million (2018-2023)
  • Table 33. Rest of Asia-Pacific Isoxazolines Drugs, by Type USD Million (2018-2023)
  • Table 34. Rest of Asia-Pacific Isoxazolines Drugs, by Pets USD Million (2018-2023)
  • Table 35. Europe Isoxazolines Drugs, by Country USD Million (2018-2023)
  • Table 36. Europe Isoxazolines Drugs, by Type USD Million (2018-2023)
  • Table 37. Europe Isoxazolines Drugs, by Pets USD Million (2018-2023)
  • Table 38. Germany Isoxazolines Drugs, by Type USD Million (2018-2023)
  • Table 39. Germany Isoxazolines Drugs, by Pets USD Million (2018-2023)
  • Table 40. France Isoxazolines Drugs, by Type USD Million (2018-2023)
  • Table 41. France Isoxazolines Drugs, by Pets USD Million (2018-2023)
  • Table 42. Italy Isoxazolines Drugs, by Type USD Million (2018-2023)
  • Table 43. Italy Isoxazolines Drugs, by Pets USD Million (2018-2023)
  • Table 44. United Kingdom Isoxazolines Drugs, by Type USD Million (2018-2023)
  • Table 45. United Kingdom Isoxazolines Drugs, by Pets USD Million (2018-2023)
  • Table 46. Netherlands Isoxazolines Drugs, by Type USD Million (2018-2023)
  • Table 47. Netherlands Isoxazolines Drugs, by Pets USD Million (2018-2023)
  • Table 48. Rest of Europe Isoxazolines Drugs, by Type USD Million (2018-2023)
  • Table 49. Rest of Europe Isoxazolines Drugs, by Pets USD Million (2018-2023)
  • Table 50. MEA Isoxazolines Drugs, by Country USD Million (2018-2023)
  • Table 51. MEA Isoxazolines Drugs, by Type USD Million (2018-2023)
  • Table 52. MEA Isoxazolines Drugs, by Pets USD Million (2018-2023)
  • Table 53. Middle East Isoxazolines Drugs, by Type USD Million (2018-2023)
  • Table 54. Middle East Isoxazolines Drugs, by Pets USD Million (2018-2023)
  • Table 55. Africa Isoxazolines Drugs, by Type USD Million (2018-2023)
  • Table 56. Africa Isoxazolines Drugs, by Pets USD Million (2018-2023)
  • Table 57. North America Isoxazolines Drugs, by Country USD Million (2018-2023)
  • Table 58. North America Isoxazolines Drugs, by Type USD Million (2018-2023)
  • Table 59. North America Isoxazolines Drugs, by Pets USD Million (2018-2023)
  • Table 60. United States Isoxazolines Drugs, by Type USD Million (2018-2023)
  • Table 61. United States Isoxazolines Drugs, by Pets USD Million (2018-2023)
  • Table 62. Canada Isoxazolines Drugs, by Type USD Million (2018-2023)
  • Table 63. Canada Isoxazolines Drugs, by Pets USD Million (2018-2023)
  • Table 64. Mexico Isoxazolines Drugs, by Type USD Million (2018-2023)
  • Table 65. Mexico Isoxazolines Drugs, by Pets USD Million (2018-2023)
  • Table 66. Isoxazolines Drugs: by Type(USD/Units)
  • Table 67. Company Basic Information, Sales Area and Its Competitors
  • Table 68. Company Basic Information, Sales Area and Its Competitors
  • Table 69. Company Basic Information, Sales Area and Its Competitors
  • Table 70. Company Basic Information, Sales Area and Its Competitors
  • Table 71. Isoxazolines Drugs: by Type(USD Million)
  • Table 72. Isoxazolines Drugs Sarolaner , by Region USD Million (2025-2030)
  • Table 73. Isoxazolines Drugs Lotilaner , by Region USD Million (2025-2030)
  • Table 74. Isoxazolines Drugs Fluralaner , by Region USD Million (2025-2030)
  • Table 75. Isoxazolines Drugs Afoxolaner , by Region USD Million (2025-2030)
  • Table 76. Isoxazolines Drugs: by Pets(USD Million)
  • Table 77. Isoxazolines Drugs Cat , by Region USD Million (2025-2030)
  • Table 78. Isoxazolines Drugs Dog , by Region USD Million (2025-2030)
  • Table 79. South America Isoxazolines Drugs, by Country USD Million (2025-2030)
  • Table 80. South America Isoxazolines Drugs, by Type USD Million (2025-2030)
  • Table 81. South America Isoxazolines Drugs, by Pets USD Million (2025-2030)
  • Table 82. Brazil Isoxazolines Drugs, by Type USD Million (2025-2030)
  • Table 83. Brazil Isoxazolines Drugs, by Pets USD Million (2025-2030)
  • Table 84. Argentina Isoxazolines Drugs, by Type USD Million (2025-2030)
  • Table 85. Argentina Isoxazolines Drugs, by Pets USD Million (2025-2030)
  • Table 86. Rest of South America Isoxazolines Drugs, by Type USD Million (2025-2030)
  • Table 87. Rest of South America Isoxazolines Drugs, by Pets USD Million (2025-2030)
  • Table 88. Asia Pacific Isoxazolines Drugs, by Country USD Million (2025-2030)
  • Table 89. Asia Pacific Isoxazolines Drugs, by Type USD Million (2025-2030)
  • Table 90. Asia Pacific Isoxazolines Drugs, by Pets USD Million (2025-2030)
  • Table 91. China Isoxazolines Drugs, by Type USD Million (2025-2030)
  • Table 92. China Isoxazolines Drugs, by Pets USD Million (2025-2030)
  • Table 93. Japan Isoxazolines Drugs, by Type USD Million (2025-2030)
  • Table 94. Japan Isoxazolines Drugs, by Pets USD Million (2025-2030)
  • Table 95. India Isoxazolines Drugs, by Type USD Million (2025-2030)
  • Table 96. India Isoxazolines Drugs, by Pets USD Million (2025-2030)
  • Table 97. South Korea Isoxazolines Drugs, by Type USD Million (2025-2030)
  • Table 98. South Korea Isoxazolines Drugs, by Pets USD Million (2025-2030)
  • Table 99. Taiwan Isoxazolines Drugs, by Type USD Million (2025-2030)
  • Table 100. Taiwan Isoxazolines Drugs, by Pets USD Million (2025-2030)
  • Table 101. Australia Isoxazolines Drugs, by Type USD Million (2025-2030)
  • Table 102. Australia Isoxazolines Drugs, by Pets USD Million (2025-2030)
  • Table 103. Rest of Asia-Pacific Isoxazolines Drugs, by Type USD Million (2025-2030)
  • Table 104. Rest of Asia-Pacific Isoxazolines Drugs, by Pets USD Million (2025-2030)
  • Table 105. Europe Isoxazolines Drugs, by Country USD Million (2025-2030)
  • Table 106. Europe Isoxazolines Drugs, by Type USD Million (2025-2030)
  • Table 107. Europe Isoxazolines Drugs, by Pets USD Million (2025-2030)
  • Table 108. Germany Isoxazolines Drugs, by Type USD Million (2025-2030)
  • Table 109. Germany Isoxazolines Drugs, by Pets USD Million (2025-2030)
  • Table 110. France Isoxazolines Drugs, by Type USD Million (2025-2030)
  • Table 111. France Isoxazolines Drugs, by Pets USD Million (2025-2030)
  • Table 112. Italy Isoxazolines Drugs, by Type USD Million (2025-2030)
  • Table 113. Italy Isoxazolines Drugs, by Pets USD Million (2025-2030)
  • Table 114. United Kingdom Isoxazolines Drugs, by Type USD Million (2025-2030)
  • Table 115. United Kingdom Isoxazolines Drugs, by Pets USD Million (2025-2030)
  • Table 116. Netherlands Isoxazolines Drugs, by Type USD Million (2025-2030)
  • Table 117. Netherlands Isoxazolines Drugs, by Pets USD Million (2025-2030)
  • Table 118. Rest of Europe Isoxazolines Drugs, by Type USD Million (2025-2030)
  • Table 119. Rest of Europe Isoxazolines Drugs, by Pets USD Million (2025-2030)
  • Table 120. MEA Isoxazolines Drugs, by Country USD Million (2025-2030)
  • Table 121. MEA Isoxazolines Drugs, by Type USD Million (2025-2030)
  • Table 122. MEA Isoxazolines Drugs, by Pets USD Million (2025-2030)
  • Table 123. Middle East Isoxazolines Drugs, by Type USD Million (2025-2030)
  • Table 124. Middle East Isoxazolines Drugs, by Pets USD Million (2025-2030)
  • Table 125. Africa Isoxazolines Drugs, by Type USD Million (2025-2030)
  • Table 126. Africa Isoxazolines Drugs, by Pets USD Million (2025-2030)
  • Table 127. North America Isoxazolines Drugs, by Country USD Million (2025-2030)
  • Table 128. North America Isoxazolines Drugs, by Type USD Million (2025-2030)
  • Table 129. North America Isoxazolines Drugs, by Pets USD Million (2025-2030)
  • Table 130. United States Isoxazolines Drugs, by Type USD Million (2025-2030)
  • Table 131. United States Isoxazolines Drugs, by Pets USD Million (2025-2030)
  • Table 132. Canada Isoxazolines Drugs, by Type USD Million (2025-2030)
  • Table 133. Canada Isoxazolines Drugs, by Pets USD Million (2025-2030)
  • Table 134. Mexico Isoxazolines Drugs, by Type USD Million (2025-2030)
  • Table 135. Mexico Isoxazolines Drugs, by Pets USD Million (2025-2030)
  • Table 136. Isoxazolines Drugs: by Type(USD/Units)
  • Table 137. Research Programs/Design for This Report
  • Table 138. Key Data Information from Secondary Sources
  • Table 139. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Isoxazolines Drugs: by Type USD Million (2018-2023)
  • Figure 5. Global Isoxazolines Drugs: by Pets USD Million (2018-2023)
  • Figure 6. South America Isoxazolines Drugs Share (%), by Country
  • Figure 7. Asia Pacific Isoxazolines Drugs Share (%), by Country
  • Figure 8. Europe Isoxazolines Drugs Share (%), by Country
  • Figure 9. MEA Isoxazolines Drugs Share (%), by Country
  • Figure 10. North America Isoxazolines Drugs Share (%), by Country
  • Figure 11. Global Isoxazolines Drugs: by Type USD/Units (2018-2023)
  • Figure 12. Global Isoxazolines Drugs share by Players 2023 (%)
  • Figure 13. BCG Matrix for key Companies
  • Figure 14. Zoetis Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 15. Zoetis Inc. (United States) Revenue: by Geography 2023
  • Figure 16. Elanco Animal Health Incorporated (United States) Revenue, Net Income and Gross profit
  • Figure 17. Elanco Animal Health Incorporated (United States) Revenue: by Geography 2023
  • Figure 18. Boehringer Ingelheim International GmbH (Germany) Revenue, Net Income and Gross profit
  • Figure 19. Boehringer Ingelheim International GmbH (Germany) Revenue: by Geography 2023
  • Figure 20. Elanco Animal Health Incorporated (United States) Revenue, Net Income and Gross profit
  • Figure 21. Elanco Animal Health Incorporated (United States) Revenue: by Geography 2023
  • Figure 22. Global Isoxazolines Drugs: by Type USD Million (2025-2030)
  • Figure 23. Global Isoxazolines Drugs: by Pets USD Million (2025-2030)
  • Figure 24. South America Isoxazolines Drugs Share (%), by Country
  • Figure 25. Asia Pacific Isoxazolines Drugs Share (%), by Country
  • Figure 26. Europe Isoxazolines Drugs Share (%), by Country
  • Figure 27. MEA Isoxazolines Drugs Share (%), by Country
  • Figure 28. North America Isoxazolines Drugs Share (%), by Country
  • Figure 29. Global Isoxazolines Drugs: by Type USD/Units (2025-2030)
List of companies from research coverage that are profiled in the study
  • Zoetis Inc. (United States)
  • Elanco Animal Health Incorporated (United States)
  • Boehringer Ingelheim International GmbH (Germany)
  • Elanco Animal Health Incorporated (United States)
Select User Access Type

Key Highlights of Report


Mar 2024 227 Pages 77 Tables Base Year: 2023 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Isoxazolines Drugs Market Quantitative research analysis
Global Isoxazolines Drugs Market Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The standard version of the report profiles players such as Zoetis Inc. (United States), Elanco Animal Health Incorporated (United States), Boehringer Ingelheim International GmbH (Germany) and Elanco Animal Health Incorporated (United States) etc.
The Study can be customized subject to feasibility and data availability. Please connect with our sales representative for further information.
"Environment-friendly Interventions to Increase the Availability of Efficacious Treatments" is seen as one of major influencing trends for Isoxazolines Drugs Market during projected period 2023-2030.
The Isoxazolines Drugs market study includes a random mix of players, including both market leaders and some top growing emerging players. Connect with our sales executive to get a complete company list in our research coverage.

Know More About Global Isoxazolines Drugs Market Report?

Have a Query? Click Here

Other Related Reports

Uygur Medicine Comprehensive Study by Application (Liver Disease, Digestive Disease, Leucoderma, Diabetes, Others), Usage (Plant, Animal, Mineral), Form (Pill, Tablet, Granule, Others), Medicinal Tas...
$ 3800
Plant Extract Drug Comprehensive Study by Application (Foods Industries, Medicine, Cosmetics, Health Sector), Drugs (Galantamine, Apomorphine, Tiotropium bromide, Varenicline, Others), Plant Extracti...
$ 3500
Azelastine Drug Comprehensive Study by Application (Seasonal allergic rhinitis, Vasomotor rhinitis), Routes Administration (Eye drops, Nasal spray, Mouth) Players and Region - Global Market Outlook t...
$ 3400
Marine Drug Comprehensive Study by Distribution Channel (Online {Company Website, E-Commerce Website}, Offline {Pharma Stores, Local Medical Stores}), End Use (Hospitals, Clinics, Diagnostic Centers)...
$ 3800
Anal Fistula Drugs Comprehensive Study by Application (Hospitals, Ambulatory Surgical Centers, Others), Treatment (Fistulotomy, Filling the Fistula with a special Glue or Plug, Reconstructive Surgery...
$ 4000
Digital Neuritis Drug Comprehensive Study by Application (Children, Adult), Disease Type (Dorsal Digital Nerves, Palmar Digital Nerves, Plantar Digital Nerves), Form (Injections, Topical), Sales Chan...
$ 3800